Compare Amgen, Inc. (AMGN) vs Nokia Corp (NOK) Price & Performance

AMGN trades at $363.39, down slightly by 0.06% today, with a bullish technical signal from moving averages. The company reported strong Q1 2026 earnings, beating estimates with EPS of $5.15 versus $4.77 expected. Revenue grew to $36.75B in 2025, with a net income margin of 20.96%. Recent news includes a favorable court ruling blocking a price cap on Enbrel in Colorado, but regulatory challenges persist for Tavneos in Europe.

The outlook remains positive due to consistent earnings beats and a diversified product portfolio, though risks include regulatory setbacks and competitive pressures. Analyst consensus is bullish with a 57.9% buy rating and a price target of $357.38, slightly below the current price, indicating potential for stability with upside from pipeline developments.

Nokia (NOK) trades at $12.43, down 3.72% amid a broader market pullback, despite strong year-to-date gains driven by AI infrastructure optimism. The stock shows mixed signals with a bearish technical outlook but positive analyst sentiment, including a $18.00 consensus price target. Recent earnings have been mixed, with a Q1 2026 miss after previous beats, while fundamentals indicate modest profitability with a 3.98% net margin and elevated P/E of 78.03. The company's pivot to AI networking, including partnerships with Nvidia and Orange Belgium, fuels growth expectations.

Outlook: NOK's AI-driven transformation offers upside potential, but high valuation and execution risks warrant caution. Near-term performance hinges on Q2 2026 earnings due July 23, which could validate AI revenue streams. Risks include competitive pressures and reliance on telecom spending cycles. Analyst bullishness suggests 45% upside to target, though technical weakness may persist short-term.